In this video, we will learn about:
1. Class identification of Tocilizumab.
2. Relative and absolute contraindications and adverse effects of Tocilizumab.
3. Mechanism of actions of the IL-6 on liver, bone marrow and immune system.
4. Rationale of Tocilizumab administration in severe COVID-19.
5. Study about effects of different doses of Tocilizumab on COVID-19 prognosis.
6. A mention of a French Study on Tocilizumab use in COVID-19
Presented by Dr. Mobeen Syed
Mobeen Syed M.D, MS Graduated from King Edward Medical University. Entrepreneur, Medical Educator, CEO and founder of Drbeen corp.